UK markets close in 1 hour 55 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
37.90+0.15 (+0.38%)
As of 09:31AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8886
Avg. Estimate-0.58-0.59-2.31-2.95
Low estimate-0.65-0.71-2.65-3.43
High estimate-0.51-0.49-1.9-2.67
Year ago EPS-0.65-0.81-2.92-2.31
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5576
Avg. Estimate950k960k2.72M2.77M
Low estimateN/AN/AN/AN/A
High estimate1.6M1.6M5.2M5.4M
Year ago sales268k1.52M6.88M2.72M
Sales growth (year/est)254.50%-36.70%-60.50%1.80%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.67-0.68-0.74-0.69
Actual EPS-0.65-0.81-0.83-0.56
Difference0.02-0.13-0.090.13
Surprise %3.00%-19.10%-12.20%18.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.58-0.59-2.31-2.95
7 days ago-0.58-0.59-2.31-2.95
30 days ago-0.71-0.72-3.01-3.09
60 days ago-0.71-0.72-3.01-3.09
90 days ago-0.74-0.77-3.1-3.2
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days5474
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLDXIndustrySector(s)S&P 500
Current qtr.10.80%N/AN/AN/A
Next qtr.27.20%N/AN/AN/A
Current year20.90%N/AN/AN/A
Next year-27.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A